Miracor Medical Systems GmbH secures EUR 7M/$ 10M in Series B Financing Round for the PICSO® technology


The financing round was supported by Austria Wirtschaftsservice (aws) and German venture capital investors SHS Gesellschaft für Beiteiligungsmanagement as well as the existing investors Earlybird and Delta Partners. Miracor will in 2011 initiate the post CE-mark “Prepare RAMSES” clinical trial and will also start initial sales activities in selected hospitals in Europe. The company plans to initiate the randomized multi-centre RAMSES trial in 2012 at the same time as it will expand its European sales activities.

BYTEC has developed and manufactures the command-console of the PICSO® and with it a valuable contribution to the success of Miracor.